Analyst Upgrade Fails to Lift Pfizer (NYSE:PFE)’s Stock
Pharmaceutical blue chip Pfizer Inc (NYSE:PFE)’s stock receive analyst upgrades on Tuesday but the news was not well-received by investors as PFE’s shares were trading 0.57 percent lower from the…